{"organizations": [], "uuid": "21b0c8c5cfa99575f1a40d4a3dbdc201da17519d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-lincoln-park-capital-reports-999-p/brief-lincoln-park-capital-reports-9-99-pct-passive-stake-in-rxi-pharmaceuticals-idUSFWN1RQ09R", "country": "US", "domain_rank": 408, "title": "BRIEF-Lincoln Park Capital Reports 9.99 Pct Passive Stake In Rxi Pharmaceuticals", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-13T14:17:00.000+03:00", "replies_count": 0, "uuid": "21b0c8c5cfa99575f1a40d4a3dbdc201da17519d"}, "author": "", "url": "https://www.reuters.com/article/brief-lincoln-park-capital-reports-999-p/brief-lincoln-park-capital-reports-9-99-pct-passive-stake-in-rxi-pharmaceuticals-idUSFWN1RQ09R", "ord_in_thread": 0, "title": "BRIEF-Lincoln Park Capital Reports 9.99 Pct Passive Stake In Rxi Pharmaceuticals", "locations": [], "entities": {"persons": [{"name": "rxi pharmaceuti", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "brief-lincoln park capital reports", "sentiment": "negative"}, {"name": "rxi pharmaceuticals   updated", "sentiment": "neutral"}, {"name": "sec", "sentiment": "none"}, {"name": "rxi pharmaceuticals corp", "sentiment": "none"}, {"name": "rxi pharmaceuticals corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 21 AM / Updated 3 minutes ago BRIEF-Lincoln Park Capital Reports 9.99 Pct Passive Stake In Rxi Pharmaceuticals   \nApril 13 (Reuters) - Rxi Pharmaceuticals Corp: \n* LINCOLN PARK CAPITAL FUND, LLC REPORTS 9.99 PCT PASSIVE STAKE IN RXI PHARMACEUTICALS CORP AS OF APRIL 9, 2018 SEC FILING Source: ( bit.ly/2HzQ63m ) Further company coverage:", "external_links": [], "published": "2018-04-13T14:17:00.000+03:00", "crawled": "2018-04-13T14:35:03.004+03:00", "highlightTitle": ""}